Thursday, May 2, 2019

USFDA for voluntary action by Sun Pharma on Dadra plant observations

USFDA for voluntary action by Sun Pharma on Dadra plant observations The health regulator had inspected the company#39;s Dadra facility from March 22 - March 29, 2019; and at the conclusion of the inspection, had issued a Form 483, with 11 observations to the company.

from Moneycontrol Business News http://bit.ly/2VCTlAz

No comments:

Post a Comment

Nifty eyes relief rally on tariff hopes, FIIs remain a drag

Markets anticipate a rebound early in the shortened week following news of potential tariff removal on India. Despite oversold conditions, a...